Related references
Note: Only part of the references are listed.Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies
Martin Hoenigl et al.
MEDICAL MYCOLOGY (2012)
Optimizing management of invasive mould diseases
Samir Agrawal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
Livio Pagano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies
M. Hoenigl et al.
MYCOSES (2011)
Underestimating the Real Burden of Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients?
Martin Hoenigl et al.
CLINICAL INFECTIOUS DISEASES (2010)
The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients
S. Perkhofer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Trends in invasive fungal infections, with emphasis on invasive aspergillosis
Z. Erjavec et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy
Sotirios Tsiodras et al.
MAYO CLINIC PROCEEDINGS (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
K Thursky et al.
BONE MARROW TRANSPLANTATION (2004)
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
KA Marr et al.
BLOOD (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
